We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

148 hedge funds and large institutions have $1.32B invested in Acorda Therapeutics in 2013 Q2 according to their latest regulatory filings, with 148 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

475% more call options, than puts

Call options by funds: $14.7M | Put options by funds: $2.56M

Holders
148
Holders Change
+148
Holders Change %
–
% of All Funds
4.83%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
148
Increased
–
Reduced
–
Closed
–
Calls
$14.7M
Puts
$2.56M
Net Calls
+$12.2M
Net Calls Change
+$12.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
26
BlackRock Group
United Kingdom
$11.2M +$11.7M +2,837 New
T. Rowe Price Associates
27
T. Rowe Price Associates
Maryland
$10.7M +$11.1M +2,697 New
Norges Bank
28
Norges Bank
Norway
$9.62M +$10M +2,430 New
RCAMU
29
Rothschild & Co Asset Management US
Connecticut
$9.1M +$9.47M +2,299 New
SCA
30
SAC Capital Advisors
Connecticut
$8.46M +$8.8M +2,137 New
TCIM
31
TIAA CREF Investment Management
New York
$8.32M +$8.66M +2,103 New
Bank of America
32
Bank of America
North Carolina
$8.29M +$8.62M +2,093 New
TRSOTSOK
33
Teachers Retirement System of the State of Kentucky
Kentucky
$7.84M +$8.16M +1,981 New
Principal Financial Group
34
Principal Financial Group
Iowa
$7.53M +$7.83M +1,902 New
FWIA
35
Fort Washington Investment Advisors
Ohio
$7.29M +$7.58M +1,840 New
Prudential Financial
36
Prudential Financial
New Jersey
$6.93M +$7.21M +1,750 New
PAMU
37
Pictet Asset Management (UK)
United Kingdom
$6.46M +$6.72M +1,631 New
Charles Schwab
38
Charles Schwab
California
$6.45M +$6.37M +1,548 New
SCM
39
Sigma Capital Management
Connecticut
$6.22M +$6.47M +1,572 New
Geode Capital Management
40
Geode Capital Management
Massachusetts
$5.73M +$5.96M +1,448 New
Ameriprise
41
Ameriprise
Minnesota
$5.73M +$5.96M +1,447 New
Wells Fargo
42
Wells Fargo
California
$5.41M +$5.63M +1,367 New
MAA
43
Managed Account Advisors
New Jersey
$5.1M +$5.3M +1,288 New
BIM
44
BlackRock Investment Management
Delaware
$4.25M +$4.42M +1,074 New
Millennium Management
45
Millennium Management
New York
$4.23M +$4.39M +1,067 New
CIM
46
Calvert Investment Management
Maryland
$4.18M +$4.35M +1,056 New
CCMH
47
Cornerstone Capital Management Holdings
New York
$3.86M +$4.01M +974 New
TCM
48
Tekla Capital Management
Massachusetts
$3.72M +$3.87M +941 New
GC
49
Guggenheim Capital
Illinois
$3.63M +$3.77M +916 New
ARC
50
Absolute Return Capital
Massachusetts
$3.59M +$3.74M +908 New
1
2
3 4 5

ACOR Hedge Fund Activity: Q2 2013 in Review

148 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2013, worth a combined $1.32B.

Buyers outnumbered sellers: 148 funds opened new ACOR positions and 0 closed out — a net gain of 148 holders — while 0 added to existing stakes and 0 trimmed.

  • 148 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.32B of Acorda Therapeutics stock for Q2 2013.
  • 148 funds opened new Acorda Therapeutics positions in Q2 2013 and 0 closed out, a net change of +148 holders.

Based on aggregated 13F filings for Q2 2013.